Home › Clinical investigation of rivaroxaban extended into important areas...
 

Keywords :   


Clinical investigation of rivaroxaban extended into important areas...

2014-09-02 16:45:54| Chemicals - Topix.net

Bayer HealthCare and its development partner Janssen Research & Development, LLC have announced an expansion of the global clinical development programme for the oral Factor Xa inhibitor, rivaroxaban, for the prevention of potentially deadly blood clots in patients at risk of venous and arterial thromboembolism : Rivaroxaban, Xarelto, has already ... (more)

Tags: important areas extended clinical

Category:Chemicals

Latest from this category

All news
12.11Benjamin Moore Expands Partnership with Roadie to Accelerate Paint Delivery for DIYers and Pros
11.11Clariant Launches Melamine-free Flame Retardant for Intumescent Coatings
11.11Protech Group Acquires Caldwell Chemical Coatings
11.11Asian Paints Reports 2Q 2024-25 Fiscal Results
10.11Clariant Launches Melamine-free Flame Retardant for Intumescent Coatings
Chemicals »
23.11 BUG ! TOO !
23.11BTS 10 FESTA ARMY JUNGKOOK
23.11 SAO 2015
23.1178580g
23.112
23.1170
23.11 BOX
23.11
More »